News | Artificial Intelligence | March 31, 2020

Infervision Launches Solution to Fight Against Coronavirus

The Chinese start-up company Infervision launches its AI-based solution InferRead CT Lung Covid-19 also in Europe

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 The Chinese start-up company Infervision launches its AI-based solution InferRead CT Lung Covid-19 also in Europe
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 The Chinese start-up company Infervision launches its AI-based solution InferRead CT Lung Covid-19 also in Europe

Professor Liming Xia, M.D.

March 31, 2020 — Lung infections generated by the coronavirus can be detected in computed tomography (CT) images. Radiologists at Tongji Hospital in Wuhan, China, had already determined this before the outbreak of the epidemic. The hospital, with 6,000 beds, was one of the first health centers in the world to equip itself with radiological artificial intelligence (AI) solutions from Infervision in 2015, and asked the company for support when the latest crisis broke out three months ago.

In close cooperation with the Zhongnan Hospital affiliated to the University of Wuhan, a specific diagnostic solution was developed and, thanks to the extensive knowledge of Infervision's engineers, implemented ultrafast with the company's own research platform InferScholar and thousands of data sets. The diagnostic system was first deployed in the emergency department and then, due to its excellent performance and accuracy, throughout the hospital. Currently, more than 30 hospitals are already using the solution.

Success at Wuhan Hospital

Professor Liming Xia, M.D., director of radiology at Wuhan Tongji Hospital and member of the editorial board of the Chinese Journal of Radiology, explained:

"Wuhan Tongji Hospital, Tongji Medical College affiliated to Huazhong University of Science and Technology are historic partners of Infervision. The Infervision team has done an incredible job working closely with us, 24 hours a day, 7 days a week, to deliver a workable diagnostic solution for COVID 19 pneumonia at horrendous speed."

Liming Xia summarizes the benefits of InferRead CT Lung Covid-19 as following:

1. Reducing the risk of cross-contamination and pressure on staff: The hospitals are massively relieved. Patients wait for hours for examinations and results from overworked doctors. Artificial intelligence can help to reduce the workload and streamline the way care is provided.

2. Increase confidence in the diagnosis: By automatically measuring and quantifying the density, morphology and volume of lesions, artificial intelligence can provide an immediate and more reliable diagnosis.

3. The development of the disease can be predicted by comparing the scans: The automatic comparison of lesions helps doctors to monitor the patient's condition and development, while at the same time evaluating the effectiveness of treatments more accurately and quickly.

Growing interest in Europe

The Campus Bio-Medico University Hospital (UCBM) in Rome InferRead is the first European customer to use CT Lung Covid-19. The system was implemented in just a few hours. Now that screening and early diagnosis have become a priority for pandemic containment, UCBM is rapidly identifying potential COVID-19 patients, minimizing the risk of further infection.

The solution is capable of providing an early indication within seconds, and the entire analysis of a CT scan takes less than 50 seconds.

For data protection reasons, the system is usually installed directly in the hospital. Additionally, and especially for smaller hospitals, a cloud solution is being prepared.

Compared to other test procedures, the solution has eminent advantages:

  • Early diagnosis even for infections without symptoms
  • Follow-up of the disease
  • Quantification of volume and density
  • Speed
  • Independence regarding reagents, tests, laboratories and transport
  • more efficient triage and thus reduced risk of infection
  • high constant quality with convincing performance features

 

Imaging CT scan: InferRead CT Lung Covid-19 displays the focus of infection in images and calculates volume, density and prognosis. The text of the findings is also generated fully automatically to relieve the physicians.

China as a role model?

Bruno Schär, managing director of Infervision Switzerland, reports on his impressions from China in December 2019:

"I am impressed by the speed and professionalism I have seen at the People’s Hospital affliated to Peking University. Because of large number of inflow of patients, any diagnosis must be made efficiently. With the help of our AI solutions, it takes only a few minutes to use a CT room - about five times less than in Western countries. We're talking about highly efficient medicine at affordable prices. The West, it seems, still has a lot to learn in order to stop the trend of constantly rising health care costs.”

For more information: www.infervision.com

Related Coronavirus Content:

VIDEO: Use of Telemedicine in Medical Imaging During COVID-19

VIDEO: How China Leveraged Health IT to Combat COVID-19

 CDRH Issues Letter to Industry on COVID-19

Qure.ai Launches Solutions to Help Tackle COVID19 

ASRT Deploys COVID-19 Resources for Educational Programs

Study Looks at CT Findings of COVID-19 Through Recovery

VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)

The Cardiac Implications of Novel Coronavirus

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Radiology Lessons for Coronavirus From the SARS and MERS Epidemics

Deployment of Health IT in China’s Fight Against the COVID-19 Epidemic

Emerging Technologies Proving Value in Chinese Coronavirus Fight

Radiologists Describe Coronavirus CT Imaging Features

Coronavirus Update from the FDA

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia 

Find more related clinical content Coronavirus (COVID-19)

Related Content

Researchers from Tokyo Metropolitan University have surveyed the amount of gadolinium found in river water in Tokyo. Gadolinium is contained in contrast agents given to patients undergoing medical magnetic resonance imaging (MRI) scans, and it has been shown in labs to become toxic when exposed to ultraviolet rays. The researchers found significantly elevated levels, particularly near water treatment plants, highlighting the need for new public policy and removal technologies as MRI become even more commonp

Samples were taken along rivers around Tokyo. Measurements of rare earth element quantities indicate a clearly elevated amount of gadolinium compared to that in natural shale. Graphics courtesy of Tokyo Metropolitan University

News | Contrast Media | May 26, 2020
May 26, 2020 — Researchers from Tokyo Metropolitan...
 Recently the versatility of mixed and augmented reality products has come to the forefront of the news, with an Imperial led project at the Imperial College Healthcare NHS Trust. Doctors have been wearing the Microsoft Hololens headsets whilst working on the front lines of the COVID pandemic, to aid them in their care for their patients. IDTechEx have previously researched this market area in its report “Augmented, Mixed and Virtual Reality 2020-2030: Forecasts, Markets and Technologies”, which predicts th

Doctors wearing the Hololens Device. Source: Imperial.ac.uk

News | Artificial Intelligence | May 22, 2020
May 22, 2020 — Recently the versatility of
Lymphocytic Inflammation in a Lung from a Patient Who Died from Covid-19. The gross appearance of a lung from a patient who died from coronavirus disease 2019 (Covid-19) is shown in Panel A (the scale bar corresponds to 1 cm). The histopathological examination, shown in Panel B, revealed interstitial and perivascular predominantly lymphocytic pneumonia with multifocal endothelialitis (hematoxylin–eosin staining; the scale bar corresponds to 200 μm).

Lymphocytic Inflammation in a Lung from a Patient Who Died from Covid-19. The gross appearance of a lung from a patient who died from coronavirus disease 2019 (Covid-19) is shown in Panel A (the scale bar corresponds to 1 cm). The histopathological examination, shown in Panel B, revealed interstitial and perivascular predominantly lymphocytic pneumonia with multifocal endothelialitis (hematoxylin–eosin staining; the scale bar corresponds to 200 μm). Image courtesy of The New England Journal of Medicine

News | Coronavirus (COVID-19) | May 22, 2020
May 22, 2020 — In a new study in the New
Despite facing challenges such as limited access to personal protective equipment (PPE) following the COVID-19 outbreak, radiation oncology clinics quickly implemented safety and process enhancements that allowed them to continue caring for cancer patients, according to a new national survey from the American Society for Radiation Oncology (ASTRO).

Getty Images

News | Coronavirus (COVID-19) | May 21, 2020
May 21, 2020 — Despite facing challenges such as limited access to...
Remote reading of imaging studies on home picture archiving and communication systems (PACS) workstations can contribute to social distancing, protect vulnerable radiologists and others in the hospital, and ensure seamless interpretation capabilities in emergency scenarios, according to an open-access article published ahead-of-print by the American Journal of Roentgenology (AJR).

Srini Tridandapani, M.D., Ph.D.

News | PACS | May 21, 2020
May 21, 2020 — 
In response to the significant healthcare delivery changes brought on by COVID-19, Varian has launched new capabilities for its Noona software application, a powerful tool designed to engage cancer patients in their care for continuous reporting and symptom monitoring.
News | Radiation Oncology | May 21, 2020
May 21, 2020 — In response to the significant healthcare delivery changes brought on by...
NucleusHealth, a provider of cloud-based medical image management technology and teleradiology services, announced today that it has received Conformité Européene (CE) Mark approval for Nucleus.io.
News | Teleradiology | May 21, 2020
May 21, 2020 — NucleusHealth, a provider of cloud-based medical image management technology and teleradiology service
Actionable insight “beyond the diagnosis” enables health researchers to better understand COVID-19 progression, intervention effectiveness, and impacts on healthcare system
News | Coronavirus (COVID-19) | May 20, 2020
May 20, 2020 — Change Healthcare introduced ...